Article
Side effects of ABPM differ between various ABPM monitors
Nebenwirkungen bei der 24h-Blutdruckmessung sind zwischen verschiedenen Blutdruckmessgeräten unterschiedlich
Search Medline for
Authors
Published: | August 10, 2005 |
---|
Outline
Text
The aim of the study was to elucidate patients' experiences and complaints during ambulatory blood pressure monitoring (ABPM). Patients often give complaints during measurement. As a consequence the compliance of repeated ABPM-measurement is still problematic.
ABPM Patients who underwent an ABPM at the outpatient clinic were asked to fill in a questionnaire with 10 items on a 5 point scale, about the convenience or inconvenience of ABPM, disturbance of daily life and activities, side effects like pain and their willingness to participate in a second ABPM. Two devices (mobil-o-graph (Mob); Spacelabs (Sp)) were tested in hypertension subjects. If patients did not fill in a question, a score of 1 point (no disturbance) was given. The scores of 4 and 5 were taken together in the percentages of serious complaints. A total score was calculated for all patients. Mean (frequencies) and SD were calculated; differences between the Spacelabs and Mobil-o-graph were tested using the Sutdent t-test and the Mann-Whithney Test.
Results. 34 patients (17 male; age 58.2±14.0; 17 female; age 57.5±16.8) used the Mob and 48 patients (28 male; age 58.0±10; 20 female; age 62.0 ±14.4) used the Sp. The total score of the Sp (20.2±4.3) was significant higher (p<0.05, i.e. less tolerance) than that of the Mob (17.4±7.2). Adaptation of daily activities (Sp 18.8%, Mob 2.9%; p=0.0313), disturbing nose (Sp12.5%, Mob 0.0%; p<0.001) was significantly different between the two groups.Disturbance of sleep of the partner (Sp 22.9%, Mob 11.8%), pain induced by inflating the cuff (Sp 6.3%, Mob 5.9%) were not significant different between Sp or Mob-patients.
About 2.1 % of the Sp-patients and 5.8% of the Mob-patients had disturbing problems during biking, walking or driving a car. The Sp subjects found the procedure aggravating in 8.5% and Mob subjects in no case (0%).
The Mobil-o-graph is much better tolerated than the Spacelabs 90207, but still a considerable percentage (10 to 12 %) of the patients reproted disturbing side effects and had to adjust their daily activites.